Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer

Clinical trial NCT00313248 · COMPLETED

Trial details

NCT number: NCT00313248
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasm

Start date: 2006-04-01
Primary completion: 2008-10-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.